High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$74.1M
$74,099,682
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| NUVL |
Nuvalent, Inc.
|
CEO
10b5-1 Sell
|
2026-03-06 | $2,969,550Largex3 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 Sell
2026-02-26
$566,788x3
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-02-26 | $566,788x3 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Noci Darlene
• Officer • Chief Development Officer
10b5-1 Sell
2026-02-26
$566,682x3
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Development Officer
10b5-1 Sell
|
2026-02-26 | $566,682x3 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Noci Darlene
• Officer • Chief Development Officer
10b5-1 Sell
2026-01-29
$561,422x4
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Development Officer
10b5-1 Sell
|
2026-01-29 | $561,422x4 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -19.3%
2026-01-22
$1,575,288Large
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -19.3%
|
2026-01-22 | $1,575,288Large | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 Sell
2026-01-21
$76,888
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-01-21 | $76,888 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Noci Darlene
• Officer • Chief Development Officer
10b5-1 Sell
2025-11-28
$434,319x2
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Development Officer
10b5-1 Sell
|
2025-11-28 | $434,319x2 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
Director
Discretionary Sell
|
2025-11-24 | $35,437,488MEGA | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
Director
10b5-1 Sell
|
2025-11-24 | $820,274x8 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 Sell
|
2025-11-18 | $76,005x2 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 Sell
|
2025-11-17 | $1,989,025Largex6 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 Sell
2025-11-17
$2,552,999Largex3
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-11-17 | $2,552,999Largex3 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 Sell
2025-10-30
$2,248,943Largex8
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-10-30 | $2,248,943Largex8 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Noci Darlene
• Officer • Chief Development Officer
10b5-1 Sell
2025-10-30
$411,661x6
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Development Officer
10b5-1 Sell
|
2025-10-30 | $411,661x6 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
Director
10b5-1 Sell
|
2025-10-28 | $4,172,134Largex2 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
Director
10b5-1 Sell
|
2025-10-27 | $1,843,330Largex2 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 Sell
2025-10-20
$474,550
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-10-20 | $474,550 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 Sell
2025-10-16
$1,134,442Largex3
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2025-10-16 | $1,134,442Largex3 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CEO
10b5-1 Sell
|
2025-10-16 | $2,447,021Largex4 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 Sell
|
2025-10-15 | $144,014 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Miller Deborah Ann
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -24.1%
2025-10-15
$1,405,848Large
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -24.1%
|
2025-10-15 | $1,405,848Large | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Pelish Henry E.
• Officer • Chief Scientific Officer
10b5-1 SellΔOwn -17.7%
2025-10-15
$1,279,018Large
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Scientific Officer
10b5-1 SellΔOwn -17.7%
|
2025-10-15 | $1,279,018Large | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 Sell
|
2025-10-14 | $1,724,016Largex4 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Pelish Henry E.
• Officer • Chief Scientific Officer
10b5-1 Sell
2025-10-14
$208,699x3
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2025-10-14 | $208,699x3 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 Sell
|
2025-10-13 | $1,770,288Largex3 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Pelish Henry E.
• Officer • Chief Scientific Officer
10b5-1 SellΔOwn -10.4%
2025-10-13
$685,879
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Scientific Officer
10b5-1 SellΔOwn -10.4%
|
2025-10-13 | $685,879 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 Sell
|
2025-10-01 | $1,709,512Largex2 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 SellΔOwn -24.5%
|
2025-09-30 | $1,701,200Large | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CFO
10b5-1 SellΔOwn -10.9%
|
2025-09-29 | $645,056 | S | Form 4 |
|
NUVL
S
Nuvalent, Inc.
Noci Darlene
• Officer • Chief Development Officer
10b5-1 Sell
2025-09-29
$332,288x5
|
||||||
| NUVL |
Nuvalent, Inc.
|
Officer • Chief Development Officer
10b5-1 Sell
|
2025-09-29 | $332,288x5 | S | Form 4 |
| NUVL |
Nuvalent, Inc.
|
CEO
10b5-1 Sell
|
2025-09-15 | $2,135,055Largex3 | S | Form 4 |